Indium DTPA and Moxetumomab pasudotox
Determining the interaction of Indium DTPA and Moxetumomab pasudotox and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: indium pentetate in-111
Brand name:
Synonyms: Pentetate Indium Disodium In 111, In-111 DTPA
Generic Name: moxetumomab pasudotox
Brand name: Lumoxiti
Synonyms: Moxetumomab Pasudotox
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Indium DTPA-Moxetumomab Pasudotox-tdfk
- Indium DTPA-Moxetumomab pasudotox-tdfk Intravenous
- Indium DTPA-Moxifloxacin
- Indium DTPA-Moxifloxacin (Systemic)
- Indium DTPA-Moxifloxacin Hydrochloride
- Indium DTPA-Moxifloxacin Injection
- Moxetumomab pasudotox-Indium In-111 Pentetreotide
- Moxetumomab pasudotox-Indium Oxyquinoline
- Moxetumomab pasudotox-Indocid
- Moxetumomab pasudotox-Indocin
- Moxetumomab pasudotox-Indocin (Indomethacin Suppositories)
- Moxetumomab pasudotox-Indocin (Indomethacin Suspension)